The Lancet Oncology in conversation with

The Lancet Oncology in conversation with

Por: The Lancet Group
Editors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from early-stage breast cancer treatment to mRNA vaccines, the access to essential cancer medicines for children to measuring ovarian toxicity, and more.
70 episodios disponibles

Latest episodes of the podcast The Lancet Oncology in conversation with

Mostrando página 2 de 4

Hisham Mehanna and Sue Yom on head and neck cancer consensus recommendations 24/06/2024
Garth Strohbehn and Katie Lichter on the environmental impact of cancer treatment 28/05/2024
James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean 29/04/2024
Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials 08/04/2024
Maria Kyrgiou on innovations in gynaecological cancers and global disparities 07/03/2024
Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers 26/02/2024
Mike Sathekge on radioligand therapy of metastatic castration-resistant prostate cancer 29/01/2024
Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma 02/01/2024
Neerja Bhatla on a new quadrivalent HPV vaccine 29/11/2023
Chandra Are on the Lancet Oncology Commission on Global Cancer Surgery 01/11/2023
Philipp Karschnia on tissue sampling and processing during resection of diffuse intracranial glioma 31/10/2023
Wanda Cui on measuring ovarian toxicity 03/10/2023
Ticiana Leal on Tumour Treating Fields 01/09/2023
Xuesong Han on cancer diagnosis during the COVID-19 pandemic in the USA 02/08/2023
Carlos Fernández de Larrea and Damian Green on BCMA CAR T cells in multiple myeloma 03/07/2023
Madeline Pe on the SISAQOL initiative 31/05/2023
Kadia Petricca and Joyce Kambugu on access to essential cancer medicines for children 02/05/2023
Mark Lythgoe on UK oncology drug approval after Brexit 27/03/2023
Janet Brown on the phase 2/3 STAR trial 28/02/2023
Valerie Speirs on biomarkers in male breast cancer 30/01/2023
« Primera ‹ Anterior 1 2 3 4 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA